Roth, John ScottAnthone, Gary J.Selzer, Don J.Poulose, Benjamin K.Pierce, Richard A.Bittner, James G.Hope, William W.Dunn, Raymond M.Martindale, Robert G.Goldblatt, Matthew I.Earle, David B.Romanelli, John R.Mancini, Gregory J.Greenberg, Jacob A.Linn, John G.Parra-Davila, EduardoSandler, Bryan J.Deeken, Corey R.Badhwar, AmitSalluzzo, Jennifer L.Voeller, Guy R.2023-09-272023-09-272022Roth JS, Anthone GJ, Selzer DJ, et al. Long-Term, Prospective, Multicenter Study of Poly-4-Hydroxybutyrate Mesh (Phasix Mesh) for Hernia Repair in Cohort at Risk for Complication: 60-Month Follow-Up. J Am Coll Surg. 2022;235(6):894-904. doi:10.1097/XCS.0000000000000363https://hdl.handle.net/1805/35826Background: Long-term resorbable mesh represents a promising technology for ventral and incisional hernia repair (VIHR). This study evaluates poly-4-hydroxybutyrate mesh (P4HB; Phasix Mesh) among comorbid patients with CDC class I wounds. Study design: This prospective, multi-institutional study evaluated P4HB VIHR in comorbid patients with CDC class I wounds. Primary outcomes included hernia recurrence and surgical site infection. Secondary outcomes included pain, device-related adverse events, quality of life, reoperation, procedure time, and length of stay. Evaluations were scheduled at 1, 3, 6, 12, 18, 24, 30, 36, and 60 months. A time-to-event analysis (Kaplan-Meier) was performed for primary outcomes; secondary outcomes were reported as descriptive statistics. Results: A total of 121 patients (46 male, 75 female) 54.7 ± 12.0 years old with a BMI of 32.2 ± 4.5 kg/m 2 underwent VIHR with P4HB Mesh (mean ± SD). Fifty-four patients (44.6%) completed the 60-month follow-up. Primary outcomes (Kaplan-Meier estimates at 60 months) included recurrence (22.0 ± 4.5%; 95% CI 11.7% to 29.4%) and surgical site infection (10.1 ± 2.8%; 95% CI 3.3 to 14.0). Secondary outcomes included seroma requiring intervention (n = 9), procedure time (167.9 ± 82.5 minutes), length of stay (5.3 ± 5.3 days), reoperation (18 of 121, 14.9%), visual analogue scale-pain (change from baseline -3.16 ± 3.35 cm at 60 months; n = 52), and Carolinas Comfort Total Score (change from baseline -24.3 ± 21.4 at 60 months; n = 52). Conclusions: Five-year outcomes after VIHR with P4HB mesh were associated with infrequent complications and durable hernia repair outcomes. This study provides a framework for anticipated long-term hernia repair outcomes when using P4HB mesh.en-USAttribution-NonCommercial-NoDerivatives 4.0 InternationalHerniorrhaphyVentral herniaHydroxybutyratesIncisional herniaPainSurgical meshSurgical wound infectionArticle